Related Experiment Video
Updated: Aug 24, 2026

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Progressive nature of paroxysmal atrial fibrillation. Observations from a 14-year follow-up study
Takeshi Kato1, Takeshi Yamashita, Kouichi Sagara
1The Cardiovascular Institute, Tokyo, Japan. takeshikato@mac.com
Insights
Paroxysmal atrial fibrillation (PAF) often progresses to chronic AF, with 77.2% of patients developing the chronic form over 14 years. Key progression factors include age, left atrial dilation, and heart conditions like myocardial infarction and valvular disease.
Area of Science:
- Cardiology
- Clinical Electrophysiology
Background:
- Atrial fibrillation (AF) is presumed to progress from paroxysmal to chronic, but this clinical course lacks robust confirmation.
- Understanding the progression of AF is crucial for effective patient management and treatment strategies.
Purpose of the Study:
- To investigate the long-term clinical course of recurrent paroxysmal atrial fibrillation (PAF).
- To identify factors influencing the progression of PAF to chronic atrial fibrillation.
Main Methods:
- A longitudinal study of 171 patients with recurrent PAF, followed for a mean of 14.1 years.
- Analysis included patients with diverse cardiac conditions, assessing progression to chronic AF under conventional antiarrhythmic therapy.
Main Results:
- Over 14 years, 77.2% of patients with PAF transitioned to chronic AF (5.5% per year).
- Independent predictors for early progression to chronic AF included older age, left atrial dilation, prior myocardial infarction, and valvular heart disease.
Conclusions:
- Long-term data confirm the progressive nature of paroxysmal atrial fibrillation.
- Quantifiable evidence supports the gradual perpetuation of AF from its paroxysmal form.
Background:
Atrial fibrillation (AF) is believed to occur first as paroxysmal, then be gradually perpetuated, and finally become chronic as the end result. However, this presumed clinical course has not been well confirmed.
Methods And Results:
The clinical course of recurrent paroxysmal AF (PAF) from its onset was examined in 171 patients (mean follow-up period: 14.1+/-8.1 years). This study population consisted of patients with no structural heart disease (n=88), ischemic heart disease (n=28), dilated or hypertrophic cardiomyopathy (n=17), valvular heart disease (n=35) or other cardiac diseases. The mean age at the onset of AF was 58.3 +/-11.8 years old. During the mean follow-up period of 14.1 years, PAF eventually developed into its chronic form in 132 patients under conventional antiarrhythmic therapy (77.2%, 5.5% of patients per year). The independent factors for early development into chronic AF were aging (hazard ratio (HR) 1.27 per 10 years, 95% confidence interval (CI) 1.06-1.47)), dilated left atrium (HR 1.39 per 10 mm, 95% CI 1.11-1.69), myocardial infarction (HR 2.33, 95% CI 1.13-4.81), and valvular diseases (HR 2.29, 95% CI 1.22-4.30).
Conclusions:
The present long-term observations definitely and quantitatively revealed the progressive nature of PAF.
Related Concept Videos
Dysrhythmias III: Characteristics of Dysrhythmias
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Pulse rhythm
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac muscle...
Acute Coronary Syndrome III: Diagnostic Studies
Electrophysiology of Normal Cardiac Rhythm

